New data reported at the RSNA meeting are refueling the drive for further utilization of MR imaging in the triage and characterization of breast cancer in women at high risk for disease.
New data reported at the RSNA meeting are refueling the drive for further utilization of MR imaging in the triage and characterization of breast cancer in women at high risk for disease.
The International Breast MRI Consortium (IBMC) trial, which compared MR and screening mammography in women at genetically high risk for breast cancer, found that MR screening can detect breast cancers missed by clinical examination and x-ray mammography, according to Dr. Constance D. Lehman and colleagues at the University of Washington, Seattle.
Also participating in the IBMC trial, Dr. Mitchell D. Schnall and colleagues at the University of Pennsylvania found an unusually low sensitivity for MR (88.1%) but a relatively high specificity (67.4%). MR could predict diagnosis in patients with suspicious lesions identified before biopsy.
Dr. Sina Meisamy and colleagues at the University of Minnesota found that adding quantitative hydrogen-1 MR spectroscopy to assess choline-containing compounds bolstered four independent radiologists' ability to characterize tumors. All four readers improved their sensitivity, specificity, and accuracy.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.